|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | |
| C07K 16/24 |
| (11) | Number of the document | 2496707 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10828964.6 |
| Date of filing the European patent application | 2010-11-02 | |
| (97) | Date of publication of the European application | 2012-09-12 |
| (45) | Date of publication and mention of the grant of the patent | 2020-02-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/055062 |
| Date | 2010-11-02 |
| (87) | Number | WO 2011/056772 |
| Date | 2011-05-12 |
| (30) | Number | Date | Country code |
| 297008 P | 2010-01-21 | US | |
| 258051 P | 2009-11-04 | US |
| (72) |
PRESTA, Leonard, G., US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | ENGINEERED ANTI-TSLP ANTIBODY |
| ENGINEERED ANTI-TSLP ANTIBODY |